Dosimetric Predictors of Dysphonia after Intensity-modulated Radiotherapy for Oropharyngeal Carcinoma

Clinical Oncology

Volumn 26, Issue 1, 2014, Pages 32-38

  Sanguineti, G ^a   Ricchetti, F ^a   McNutt, T ^a   Wu, B ^a   Fiorino, C ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Dosimetric predictors; Radiotherapy; Voice changes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER RADIOTHERAPY; DYSPHONIA; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEAD AND NECK SCALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT; VERY ELDERLY; VOICE CHANGE;

DOSIMETRIC PREDICTORS; RADIOTHERAPY; VOICE CHANGES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DYSPHONIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84890792966     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.08.006     Document Type: Article

References (22)

1. O'Sullivan B., Rumble R.B., Warde P., et al. Intensity-modulated radiotherapy in the treatment of head and neck cancer. Clin Oncol 2012, 24:474-487.
2. Johnston M., Clifford S., Bromley R., et al. Volumetric-modulated arc therapy in head and neck radiotherapy: a planning comparison using simultaneous integrated boost for nasopharynx and oropharynx carcinoma. Clin Oncol 2011, 23:503-511.
3. Rancati T., Schwarz M., Allen A.M., et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010, 76:S64-S69.
4. Sanguineti G., Adapala P., Endres E.J., et al. Dosimetric predictors of laryngeal edema. Int J Radiat Oncol Biol Phys 2007, 68:741-749.
5. Ang K.K., Garden A.S. Radiotherapy for head and neck cancers 2002, Lippincott Williams and Wilkins, Philadelphia. 2nd ed.
6. Lee N., Mechalakos J., Puri D.R., et al. Choosing an intensity-modulated radiation therapy technique in the treatment ofhead-and-neck cancer. Int J Radiat Oncol Biol Phys 2007, 68:1299-1309.
7. Dabaja B., Salehpour M.R., Rosen I., et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 2005, 63:1000-1005.
8. Stoicheff M.L. Voice following radiotherapy. Laryngoscope 1975, 85:608-618.
9. Fung K., Lyden T.H., Lee J., et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005, 63:1395-1399.
10. Fung K., Yoo J., Leeper H.A., et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 2001, 111:1920-1924.
11. Fung K., Yoo J., Leeper H.A., et al. Effects of head and neck radiation therapy on vocal function. JOtolaryngol 2001, 30:133-139.
12. Vineberg K.A., Feng F.Y., Griffith K., et al. Dose-response relationship for worsening patient-reported voice quality following chemoradiation for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2009, 75:S179.
13. Sanguineti G., Sormani M.P., Marur S., et al. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2012, 83(1):235-242.
14. Rao N.G., Sanguineti G., Chaljub G., et al. Do neck levels negative on initial CT need to be dissected after definitive radiation therapy with or without chemotherapy?. Head Neck 2008, 30:1090-1098.
15. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. JClin Oncol 1993, 11:570-579.
16. List M.A., D'Antonio L.L., Cella D.F., et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 1996, 77:2294-2301.
17. Jensen K., Lambertsen K., Torkov P., et al. Patient assessed symptoms are poor predictors of objective findings. Results from a cross sectional study in patients treated with radiotherapy for pharyngeal cancer. Acta Oncol 2007, 46:1159-1168.
18. Bhide S.A., Gulliford S., Kazi R., et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 2009, 93:539-544.
19. Karnell L.H., Funk G.F., Tomblin J.B., et al. Quality of life measurements of speech in the head and neck cancer patient population. Head Neck 1999, 21:229-238.
20. Jabbari S., Kim H.M., Feng M., et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005, 63:725-731.
21. Gillison M.L. Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. JClin Oncol 2006, 24:5623-5625.
22. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. JClin Oncol 2008, 26:3582-3589.